









Markets
/
Stocks
/
nasdaq-ahg
/

Akso Health Group

AHG

1.490USD

-0.010-0.67%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

822.27MMarket Cap

LossP/E TTM



Akso Health Group

1.490

-0.010-0.67%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Akso Health Group

Currency: USD Updated: 2026-02-06

Key Insights

Akso Health Group's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 220 out of 482 in the Software & IT Services industry.Institutional ownership is very low.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Akso Health Group's Score

Industry at a Glance

Industry Ranking

220 / 482

Overall Ranking

406 / 4521

Industry

Software & IT Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Akso Health Group Highlights

StrengthsRisks

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.

Growing

The company is in a growing phase, with the latest annual income totaling USD 14.78M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 14.78M.

Undervalued

The company’s latest PE is -3.15, at a low 3-year percentile range.

Held by James Simons

Star Investor James Simons holds 129.20K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.80.

Analyst Rating

Based on 0 analysts

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Akso Health Group is 5.22, ranking 464 out of 482 in the Software & IT Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 6.93M, representing a year-over-year increase of 676.00%, while its net profit experienced a year-over-year increase of 83.03%.

Score

Industry at a Glance

Previous score

5.22

Change



Financials

2.14

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

4.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.97

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Akso Health Group's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Akso Health Group is 8.45, ranking 74 out of 482 in the Software & IT Services industry. Its current P/E ratio is -3.15, which is -83.19% below the recent high of -0.53 and -208.06% above the recent low of -9.69.

Score

Industry at a Glance

Previous score

8.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 220/482

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Akso Health Group. The Software & IT Services industry's average is 7.60.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Akso Health Group is 8.89, ranking 21 out of 482 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 1.64 and the support level at 1.33, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.98

Change

-0.09

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.007

Buy

RSI(14)

51.393

Neutral

STOCH(KDJ)(9,3,3)

58.872

Neutral

ATR(14)

0.139

Low Volatility

CCI(14)

-26.648

Neutral

Williams %R

50.000

Neutral

TRIX(12,20)

0.111

Sell

StochRSI(14)

11.759

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

1.504

Sell

MA10

1.460

Buy

MA20

1.481

Buy

MA50

1.435

Buy

MA100

1.536

Sell

MA200

1.562

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Akso Health Group is 3.00, ranking 280 out of 482 in the Software & IT Services industry. The latest institutional shareholding proportion is 0.04%, representing a quarter-over-quarter decrease of 10.29%. The largest institutional shareholder is James Simons, holding a total of 129.20K shares, representing 0.02% of shares outstanding, with 55.17% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Renaissance Technologies LLC

Star Investors

129.20K

-1.22%

Geode Capital Management, L.L.C.

14.97K

Catalina Capital Group, LLC

-100.00%

Millennium Management LLC

-100.00%

Rhumbline Advisers Ltd. Partnership

-100.00%

Geowealth Management LLC

-100.00%

UBS Financial Services, Inc.

13.03K

+0.54%

Aperio Group, LLC

37.00

Two Sigma Investments, LP

-100.00%

XTX Markets LLC

-100.00%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Software & IT Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Akso Health Group is 1.87, ranking 409 out of 482 in the Software & IT Services industry. The company's beta value is -0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.